Swiss medical technology company Juvaplus will be launching a new robotic syringe for the use of botulinum toxin injections to the UK.
The Juvapen Expert is CE marked and the company worked with the Swiss Federal Institute of Technology (EPFL) for the development of its technology.
Due to its internal mechanisms, the device produces a constant homogenous flow, enabling the toxin to distribute evenly across the designated area, reducing pain, discomfort, and visible swelling, commented Juvaplus.
Sales and marketing manager at Juvaplus, Edouard Legrand, said, “We are enormously proud to introduce the Juvapen Expert to the UK. We believe that this technology is a game changer for the aesthetic and therapeutic industry. Practitioners can provide more accurate and therefore aesthetically pleasing results for their patients by using this device.”
The device will be launching in September and unveiled at the Aesthetic and Anti-Ageing Medicine World Congress (AMWC) in Monaco.
